Abstract:This study examines in vivo the role and functional interrelationships of components regulating exit from the G1 resting phase into the DNA synthetic (S) phase of the cell cycle. Our approach made use of several key experimental attributes of the developing mouse lens, namely its strong dependence on pRb in maintenance of the postmitotic state, the down-regulation of cyclins D and E and up-regulation of the p57(KIP2) inhibitor in the postmitotic lens fiber cell compartment, and the ability to target transgene expression to this compartment. These attributes provide an ideal in vivo context in which to examine the consequences of forced cyclin expression and/or of loss of p57(KIP2) inhibitor function in a cellular compartment that permits an accurate quantitation of cellular proliferation and apoptosis rates in situ. Here, we demonstrate that, despite substantial overlap in cyclin transgene expression levels, D-type and E cyclins exhibited clear functional differences in promoting entry into S phase. In general, forced expression of the D-type cyclins was more efficient than cyclin E in driving lens fiber cells into S phase. In the case of cyclins D1 and D2, ectopic proliferation required their enhanced nuclear localization through CDK4 coexpression. High nuclear levels of cyclin E and CDK2, while not sufficient to promote efficient exit from G1, did act synergistically with ectopic cyclin D/CDK4. The functional differences between D-type and E cyclins was most evident in the p57(KIP2)-deficient lens wherein cyclin D overexpression induced a rate of proliferation equivalent to that of the pRb null lens, while overexpression of cyclin E did not increase the rate of proliferation over that induced by the loss of p57(KIP2) function. These in vivo analyses provide strong biological support for the prevailing view that the antecedent actions of cyclin D/CDK4 act cooperatively with cyclin E/CDK2 and antagonistically with p57(KIP2) to regulate the G1/S transition in a cell type highly dependent upon pRb.

Cooperation Between The Cdk Inhibitors P27(Kip1) And P57(Kip2) In The Control Of Tissue Growth And Development

Cooperation between the <i>Cdk</i> inhibitors <i>p27<sup>KIP1</sup></i> and <i>p57<sup>KIP2</sup></i> in the control of tissue growth and development

Cyclin D- and E-Dependent Kinases and the P57(Kip2) Inhibitor: Cooperative Interactions in Vivo

CDK Inhibitors: Cell Cycle Regulators and Beyond

P21(cip1) and P57(kip2) Control Muscle Differentiation at the Myogenin Step.

Functional Collaboration Between Different Cyclin-Dependent Kinase Inhibitors Suppresses Tumor Growth with Distinct Tissue Specificity

Functional Versatility of the CDK Inhibitor p57Kip2

P27kip1 and P130 Cooperate to Regulate Hematopoietic Cell Proliferation in Vivo.

Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16

Cell-cycle inhibitors: three families united by a common cause

Ubiquitylation and Proteasomal Degradation of the P21(Cip1), P27(Kip1) and P57(Kip2) Cdk Inhibitors

Cyclin K regulates prereplicative complex assembly to promote mammalian cell proliferation

P57(Kip2), A Structurally Distinct Member of the P21(Cip1) Cdk Inhibitor Family, is A Candidate Tumor-Suppressor Gene

Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development

Ubiquitylation and Proteasomal Degradation of the P21cip1, P27kip1and P57kip2cdk Inhibitors

Why minimal is not optimal: Driving the mammalian cell cycle—and drug discovery—with a physiologic CDK control network

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

Retinoblastoma tumor suppressor protein–dependent methylation of histone H3 lysine 27 is associated with irreversible cell cycle exit

Cks1: Structure, Emerging Roles and Implications in Multiple Cancers

CDK5RAP3, an essential regulator of checkpoint, interacts with RPL26 and maintains the stability of cell growth

Phosphoinositide-Dependent Protein Kinases Regulate Cell Cycle Progression Through the SAD Kinase Cdr2 in Fission Yeast